Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologists
Rheumatology Advances in Practice · 18.03.2026 · 10 (2)
DOI: 10.1093/rap/rkag050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 21.04.2026. Verfasst von Genna Braverman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences, NIH/NCATS.
Abstract (Originalsprache)
Objectives
To determine whether rheumatologists and pulmonologists have distinct disciplinary approaches to the management of systemic autoimmune rheumatic disease (SARD)-interstitial lung disease (ILD).
Methods
This was a cross-sectional survey study of US rheumatologists and pulmonologists. Surveys were electronically distributed to physicians identified through professional societies and social media. Surveys contained case questions on SARD-ILD management for patients with mixed connective tissue disease, idiopathic inflammatory myopathy, rheumatoid arthritis, systemic sclerosis and Sjogren’s with varying ILD severity (asymptomatic, symptomatic, progressive). Respondents also answered questions on treatment decision-making, comfort with pharmacologic modalities and opinions about interdisciplinary co-management. We analyzed responses submitted 5–9/2024. We compared specialists’ responses via univariate logistic regression, Chi-squared or Fisher’s exact tests; we performed multivariable logistic regression of case questions controlling for practice setting, clinical experience and geographic region.
Results
Analyses included 309 participants (rheumatologists = 184, pulmonologists = 125). Compared with pulmonologists, rheumatologists were less likely to treat asymptomatic and symptomatic ILD with corticosteroids for all SARD except asymptomatic systemic sclerosis (odds ratios [OR] 0.14–0.45), and to treat progressive ILD with antifibrotics (OR 0.26–0.30). Conversely, rheumatologists were more likely than pulmonologists to either add or modify immunomodulation/immunosuppression for all symptomatic and progressive SARD-ILD (OR 1.82–5.44). There were disciplinary differences in the relative importance of clinical variables to treatment approaches. Specialists reported ownership over different domains of treatment decision-making and healthcare maintenance.
Conclusion
This national study suggests distinct disciplinary approaches to management of SARD-ILD, and highlights opportunities to leverage complementary expertise through a co-management paradigm.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY, USA.
- Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
- Division of Pulmonary and Critical Care, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
- Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
ORCID-Profile: Genna Braverman, Kerri I Aronson, Robert Spiera
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- NIH/NCATS
- Clinical and Translational Science Center at Weill Cornell Medical College
Zitieren
APA
Braverman, G., Aronson, K. I., Thomas, C., & Spiera, R. (2026). Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologists. Rheumatology Advances in Practice, 10(2). https://doi.org/10.1093/rap/rkag050
Vancouver
Braverman G, Aronson KI, Thomas C, Spiera R. Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologists. Rheumatology Advances in Practice. 2026;10(2). doi:10.1093/rap/rkag050
BibTeX
@article{Braverman2026,
author = {Braverman, Genna and Aronson, Kerri I and Thomas, Charlene and Spiera, Robert},
title = {Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologists},
journal = {Rheumatology Advances in Practice},
year = {2026},
volume = {10},
number = {2},
doi = {10.1093/rap/rkag050}
}
EUVIMED